Investor Presentaiton
FURTHER INVESTMENT IN
Science and IP
COMVITA LABORATORIES Est. 1974
Industry Leading in
Clinical Trials
Mānuka honey for Digestive Health
(HVN National Science Challenge grant awarded: $875K)
More Scientific Patents
Granted
5 Patents Granted in FY22
To date 12 Patents Filed & 5 Granted
$1.3M
12
Industry Leading
Lab Testing Standards
392,469 Lab Results in FY22
(FY21: 246,804)
+59%
VS. PCP
Leading Scientific &
Clinical Expertise
Backed by Expert Global Advisory Board
AU, NZ, USA, UK, CHN
8
Members
World-Leading
Quality
23 Independent Audits and Certifications
Incl. BRC "AA", IANZ, MPI Recognised Lab, MPI Transitional Facility
#1
Greater Investment in
Consumer Health
Skin & Gut Health
Mānuka for Atopic Dermatitis & Digestive Health
Propolis for Immunity
$1.2M
$5.7M R&D spend qualifying for RDTI: Consumer Health $1.2M, Supply and Process Improvement $4.5M
5 patents granted (3 in the same patent family) and 12 patents filed (10 in the same patent family)
COMVITA INVESTOR PRESENTATION FULL YEAR RESULT FY22
17View entire presentation